Skip to main content
Top
Published in: Respiratory Research 1/2006

Open Access 01-12-2006 | Research

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons

Authors: R Diel, A Nienhaus, C Lange, K Meywald-Walter, M Forßbohm, T Schaberg

Published in: Respiratory Research | Issue 1/2006

Login to get access

Abstract

Background

BCG-vaccination can confound tuberculin skin test (TST) reactions in the diagnosis of latent tuberculosis infection.

Methods

We compared the TST with a Mycobacterium tuberculosis specific whole blood interferon-gamma assay (QuantiFERON®-TB-Gold In Tube; QFT-G) during ongoing investigations among close contacts of sputum smear positive source cases in Hamburg, Germany.

Results

During a 6-month period, 309 contacts (mean age 28.5 ± 10.5 years) from a total of 15 source cases underwent both TST and QFT-G testing. Of those, 157 (50.8%) had received BCG vaccination and 84 (27.2%) had migrated to Germany from a total of 25 different high prevalence countries (i.e. >20 cases/100,000). For the TST, the positive response rate was 44.3% (137/309), whilst only 31 (10%) showed a positive QFT-G result. The overall agreement between the TST and the QFT-G was low (κ = 0.2, with 95% CI 0.14.-0.23), and positive TST reactions were closely associated with prior BCG vaccination (OR 24.7; 95% CI 11.7–52.5). In contrast, there was good agreement between TST and QFT-G in non-vaccinated persons (κ = 0.58, with 95% CI 0.4–0.68), increasing to 0.68 (95% CI 0.46–0.81), if a 10-mm cut off for the TST was used instead of the standard 5 mm recommended in Germany.

Conclusion

The QFT-G assay was unaffected by BCG vaccination status, unlike the TST. In close contacts who were BCG-vaccinated, the QFT-G assay appeared to be a more specific indicator of latent tuberculosis infection than the TST, and similarly sensitive in unvaccinated contacts. In BCG-vaccinated close contacts, measurement of IFN-gamma responses of lymphocytes stimulated with M. tuberculosis-specific antigen should be recommended as a basis for the decision on whether to perform subsequent chest X-ray examinations or to start treatment for latent tuberculosis infection.
Literature
1.
go back to reference Bradford WZ, Koehler J, El-Hajj H, Hopewell PC, Reingold AL, Agasino CB, Cave MD, Rane S, Yang Z, Crane CM, Small PM: Dissemination of Mycobacterium tuberculosis across the San Francisco Bay Area. J Infect Dis 1988, 177:1104–1107.CrossRef Bradford WZ, Koehler J, El-Hajj H, Hopewell PC, Reingold AL, Agasino CB, Cave MD, Rane S, Yang Z, Crane CM, Small PM: Dissemination of Mycobacterium tuberculosis across the San Francisco Bay Area. J Infect Dis 1988, 177:1104–1107.CrossRef
2.
go back to reference Gutierrez MC, Vincent V, Aubert D, Bizet J, Gaillot O, Lebrun L, Le Pendeven C, Le Pennec MP, Mathieu D, Offredo C, Pangon B, Pierre-Audigier C: Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol 1998, 36:486–492.PubMedPubMedCentral Gutierrez MC, Vincent V, Aubert D, Bizet J, Gaillot O, Lebrun L, Le Pendeven C, Le Pennec MP, Mathieu D, Offredo C, Pangon B, Pierre-Audigier C: Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol 1998, 36:486–492.PubMedPubMedCentral
3.
go back to reference Van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD: Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 1999, 3:726–736.CrossRef Van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M, Kremer K, van Embden JD: Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 1999, 3:726–736.CrossRef
4.
go back to reference Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR: Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiological methods. N Engl J Med 1994, 330:1710–1716.CrossRefPubMed Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR: Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiological methods. N Engl J Med 1994, 330:1710–1716.CrossRefPubMed
5.
go back to reference Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994, 330:1703–1709.CrossRefPubMed Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schecter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994, 330:1703–1709.CrossRefPubMed
6.
go back to reference Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099–1104.CrossRefPubMed Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099–1104.CrossRefPubMed
7.
go back to reference Wilkinson KA, Wilkinson RJ, Pathan A, Ewer K, Prakash M, Klenermann P, Maskell N, Davies R, Pasvol G, Lalvani A: Ex vivo characterization of early secretory antigen target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005, 40:184–187.CrossRefPubMed Wilkinson KA, Wilkinson RJ, Pathan A, Ewer K, Prakash M, Klenermann P, Maskell N, Davies R, Pasvol G, Lalvani A: Ex vivo characterization of early secretory antigen target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis 2005, 40:184–187.CrossRefPubMed
8.
go back to reference Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59–64.CrossRefPubMed Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I: Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59–64.CrossRefPubMed
9.
go back to reference Ferrara G, Losi M, Meacci M, Meccugni B, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L: Routine hospital use of a commercial whole blood interferon-{gamma} assay for tuberculosis infection. Am J Respir Crit Care Med 2005, 172:631–635.CrossRefPubMed Ferrara G, Losi M, Meacci M, Meccugni B, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L: Routine hospital use of a commercial whole blood interferon-{gamma} assay for tuberculosis infection. Am J Respir Crit Care Med 2005, 172:631–635.CrossRefPubMed
10.
go back to reference Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756–2761.CrossRefPubMed Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ: Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756–2761.CrossRefPubMed
11.
go back to reference Brock I, Munk ME, Kok-Jensen A, Andersen P: Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001, 5:462–467.PubMed Brock I, Munk ME, Kok-Jensen A, Andersen P: Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001, 5:462–467.PubMed
12.
go back to reference Funayama K, Tsujimoto A, Mori M, Yamamoto H, Fujiwara K, Nishimura T, Hasegawa N, Horiguchi I, Mori T, Marui E: Usefulness of QuantiFERON ® TB-2G in contact investigation of a tuberculosis outbreak in a university. Kekkaku 2005, 80:527–534.PubMed Funayama K, Tsujimoto A, Mori M, Yamamoto H, Fujiwara K, Nishimura T, Hasegawa N, Horiguchi I, Mori T, Marui E: Usefulness of QuantiFERON ® TB-2G in contact investigation of a tuberculosis outbreak in a university. Kekkaku 2005, 80:527–534.PubMed
13.
go back to reference Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004, 170:65–69.CrossRefPubMed Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P: Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004, 170:65–69.CrossRefPubMed
14.
go back to reference Institut für Hygiene und Umwelt, Hamburg: Meldepflichtige Infektionskrankheiten in Hamburg 2004. Epidemiologischer Bericht 9. Institut für Hygiene und Umwelt, Hamburg: Meldepflichtige Infektionskrankheiten in Hamburg 2004. Epidemiologischer Bericht 9.
15.
go back to reference Statistische Ämter des Bundes und der Länder: Gebiet und Bevölkerung – Ausländische Bevölkerung. Ausgabe 2005. Statistische Ämter des Bundes und der Länder: Gebiet und Bevölkerung – Ausländische Bevölkerung. Ausgabe 2005.
16.
go back to reference Behr A, Hopewell PC, Paz EA, Kamamura LM, Schecter GF, Small PM: Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis . Am J Respir Crit Care Med 1998, 158:465–469.CrossRefPubMed Behr A, Hopewell PC, Paz EA, Kamamura LM, Schecter GF, Small PM: Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis . Am J Respir Crit Care Med 1998, 158:465–469.CrossRefPubMed
18.
go back to reference Sachs L: Angewandte Statistik: Anwendung statistischer Methoden. 10th edition. Berlin, Springer; 2002.CrossRef Sachs L: Angewandte Statistik: Anwendung statistischer Methoden. 10th edition. Berlin, Springer; 2002.CrossRef
19.
go back to reference Euro TB (CESES/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European RegionReport on tuberculosis cases notified in 1996 1998. Euro TB (CESES/KNCV) and the national coordinators for tuberculosis surveillance in the WHO European RegionReport on tuberculosis cases notified in 1996 1998.
20.
go back to reference Schaberg T, Hauer B, Loddenkemper R, Brendel A, Haas W, Just HM, Loytved G, Meyer C, Rieder HL, Ruden H, Sagebiel D: Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany. Pneumologie 2004, 58:255–70.CrossRefPubMed Schaberg T, Hauer B, Loddenkemper R, Brendel A, Haas W, Just HM, Loytved G, Meyer C, Rieder HL, Ruden H, Sagebiel D: Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany. Pneumologie 2004, 58:255–70.CrossRefPubMed
21.
go back to reference American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infectionAm J Respir Crit Care Med 2000, 161:S221–247. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infectionAm J Respir Crit Care Med 2000, 161:S221–247.
22.
go back to reference Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361:1168–1173.CrossRefPubMed Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361:1168–1173.CrossRefPubMed
23.
go back to reference Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, Andersen P, Britton WJ, Rothel JS: Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999, 6:934–937.PubMedPubMedCentral Johnson PD, Stuart RL, Grayson ML, Olden D, Clancy A, Ravn P, Andersen P, Britton WJ, Rothel JS: Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 1999, 6:934–937.PubMedPubMedCentral
24.
go back to reference Zellweger JP, Zellweger A, Ansermet S, De Senarclens B, Wrighton-Smith P: Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin test. Int J Tuberc Lung Dis 2005, 9:1242–1247.PubMed Zellweger JP, Zellweger A, Ansermet S, De Senarclens B, Wrighton-Smith P: Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin test. Int J Tuberc Lung Dis 2005, 9:1242–1247.PubMed
25.
go back to reference Hill PC, Fox A, Jeffreis DJ, Jackson-Silah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Corrah T, Adegbola RA, McAdam KP, Brookes RH: Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005, 490:273–278.CrossRef Hill PC, Fox A, Jeffreis DJ, Jackson-Silah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Corrah T, Adegbola RA, McAdam KP, Brookes RH: Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005, 490:273–278.CrossRef
26.
go back to reference Edwards LB, Acquviva FA, Livesay VT, Cross FW, Palmer CE: An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969, 99:1–111.PubMed Edwards LB, Acquviva FA, Livesay VT, Cross FW, Palmer CE: An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969, 99:1–111.PubMed
27.
go back to reference Larsson LO, Bentzon MW, Lind A, Magnusson M, Sandegard G, Skoogh BE, Boethius G: Sensitivity to sensitins and tuberculin in Swedish children. Part 5: A study of school children in an inland rural area. Tuber Lung Dis 1993, 74:371–376.CrossRefPubMed Larsson LO, Bentzon MW, Lind A, Magnusson M, Sandegard G, Skoogh BE, Boethius G: Sensitivity to sensitins and tuberculin in Swedish children. Part 5: A study of school children in an inland rural area. Tuber Lung Dis 1993, 74:371–376.CrossRefPubMed
28.
go back to reference Tala-Heikkila M, Nurmela T, Misljenovic O, Bleiker MA, Tala E: Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tuber Lung Dis 1992, 73:87–93.CrossRefPubMed Tala-Heikkila M, Nurmela T, Misljenovic O, Bleiker MA, Tala E: Sensitivity to PPD tuberculin and M. scrofulaceum sensitin in schoolchildren BCG vaccinated at birth. Tuber Lung Dis 1992, 73:87–93.CrossRefPubMed
29.
go back to reference Bruins J, Gribnau JH, Bwire R: Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tuber Lung Dis 1995, 76:540–544.CrossRefPubMed Bruins J, Gribnau JH, Bwire R: Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tuber Lung Dis 1995, 76:540–544.CrossRefPubMed
30.
go back to reference Von Reyn, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, Weber DJ, Tosteson AN: Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001, 5:1122–1128. Von Reyn, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, Weber DJ, Tosteson AN: Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001, 5:1122–1128.
31.
go back to reference Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA: Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 2005, 11:195–202.CrossRefPubMed Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA: Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med 2005, 11:195–202.CrossRefPubMed
Metadata
Title
Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons
Authors
R Diel
A Nienhaus
C Lange
K Meywald-Walter
M Forßbohm
T Schaberg
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2006
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-7-77

Other articles of this Issue 1/2006

Respiratory Research 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.